BFS secures place on FP6 R&D Project Team
Blue Fountain are part of a successful consortium to win an FP6 research and development project. The project “Nanospad” brings together a range of universities, research institutes and private companies from across Europe to research and develop a miniaturized diagnostic tool for use in the identification and treatment of allergies. BFS have the key responsibility for developing the software interface for the system together with the management and dissemination of all data produced.
Becoming part of a European research and technology development project was a strategic goal for the company with FP6 viewed as an opportunity to broaden the profile of Blue Fountain in Europe and to improve the technical expertise within the company. Aidan McGuire said “People understand that FP6 is highly competitive, to be successful is a good reflection of our capabilities."
Blue Fountain worked with FrameworksNW to secure the project.
Set up in 2003, FrameworksNW is establishing itself as an important gateway for accessing funds under the European Union's Euro 19bn funding pot for collaborative R&D.
Aidan explained “Not only did FramworksNW find us a suitable project, but one in health care, a market we specialise in. They have helped every step of the way. Without their support we would have given up.”
BFS are already involved in a second proposal.
“These projects have the potential to change our business and we see real long term value in them. I would have no hesitation in recommending FrameworksNW.”
Ritchie Head
from FrameworksNW added “People running businesses do not have time
to fully understand the proposal process, we provide short cuts and
informed advice."
